Lund Protein Production Platform (LP3) is a platform that has relevance and ties to all 3 of the infrastructures in InfraLife. In March, InfraLife Project Coordinator,… Read More »InfraLife visit to the Lund Protein Production platform-LP3.
InfraLife connected Environment stakeholders from SciLifeLab’s Planetary Biology capability and LINXS Environment & Climate theme with scientists at MAX IV. One of the goals of… Read More »SciLifeLab Planetary Biology Capability visit MAX IV.
In March 2024, MAX IV representatives visited the SciLifeLab Gothenburg site to give a seminar and to visit research infrastructures. During the seminar, an introduction… Read More »MAX IV seminar and site visits to SciLifeLab Gothenburg.
“How SciLifeLab and MAX IV collaborated with SARomics Biostructures in drug discovery projects” InfraLife hosted its first Industry user case outreach webinar where participants could… Read More »Industry case webinar on drug discovery
InfraLife participated in the NLS days in Copenhagen-Denmark, to interact with life science industry and other stakeholders. We displayed current offers and were available for… Read More »Nordic Life Science days 2023
Navinci, a biotech pioneer committed to pushing the boundaries of spatial proteomics, e.g., visualizing localizations of proteins and their interactions at the cellular and subcellular… Read More »Industry Case: SciLifeLab Spatial Proteomics key in enhancing advanced Navinci products and Lunaphore technology
InfraLife participated in the SciLifeLab site inauguration days to present InfraLife and meet the life science community through out Sweden. The SciLifeLab site days was… Read More »InfraLife at SciLifeLab site days
Kaffe Bueno aims to unlock the value of coffee by-products, benefiting personal care, nutraceuticals, and functional foods. Their collaboration with SciLifeLab’s NMR Centre in Umeå, focusing… Read More »Industry Case: Unlocking Coffee’s Hidden Potential – A Collaboration Between Kaffe Bueno and SciLifeLab
InfraLife happily hosted SciLifeLab members from all over Sweden at ESS and MAX IV. The delegation got to see the infrastructures from the inside, learn about their potential in life science… Read More »ESS and MAX IV tour and mingle
The biopharmaceutical company Lipum specializes in the discovery and development of novel drugs to treat diseases related to chronic inflammation. The company has developed its… Read More »Industry case: With support from two SciLifeLab service areas, Lipum AB develops a biomarker assay to support the development of a novel drug for chronic inflammation